Biotherapies in Solid Tumors: Are Negative Results Still of Low Priority for Publication?

In 2005, we performed the largest survey on clinical trials of biotherapies for all solid tumors and found indirect evidence of a publication bias: editors of medical journals were more prone to publish positive results independently from the quality of the studies. We collected data from 2003 to 20...

Descripción completa

Detalles Bibliográficos
Autores principales: Ottaiano, Alessandro, Cassata, Antonino, Capozzi, Monica, De Divitiis, Chiara, De Stefano, Alfonso, Avallone, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861183/
https://www.ncbi.nlm.nih.gov/pubmed/29594042
http://dx.doi.org/10.3389/fonc.2018.00062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861183/
https://www.ncbi.nlm.nih.gov/pubmed/29594042
http://dx.doi.org/10.3389/fonc.2018.00062

Ejemplares similares